News › Industry News

Alastin Skincare Receives Patent for Topical Composition

July 22, 2020

Alastin Skincare, Inc.—a specialty aesthetics company dedicated to developing and marketing clinically tested, physician-dispensed skin care products—has announced that the United States Patent and Trademark Office has issued a fourth U.S. Patent, No. 10,688,147, incorporating Alastin’s platform TriHex Technology. The patent is directed to a topical composition for alleviating bruising caused by a cosmetic procedure—INhance Post-Injection Serum with TriHex Technology.
Read more at PR Newswire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • FDA Approves Belotero Volume and Belotero Intense
    • Ad IntellX Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • SafeLink Consulting Inc. Launches SafeLink360, Bringing Risk & Compliance Management and Expert Support Together in One Platform
    • TITAN Aesthetic Founder Mary Beth Hagen Transfers Ownership to Carrie Galpin
    • AmSpa’s Medical Spa Show Voted Best Tradeshow Injectable Education
Advertisement